Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

37.40
-0.2000-0.53%
Post-market: 37.34-0.0600-0.16%19:30 EDT
Volume:1.60M
Turnover:59.67M
Market Cap:5.03B
PE:-10.74
High:38.14
Open:37.70
Low:36.86
Close:37.60
52wk High:49.70
52wk Low:10.46
Shares:134.37M
Float Shares:129.97M
Volume Ratio:0.66
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4823
EPS(LYR):-2.0600
ROE:-64.09%
ROA:-20.64%
PB:5.47
PE(LYR):-18.16

Loading ...

OverviewCompanyNewsFilings

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live
·
Aug 13

Definium Therapeutics Price Target Raised to $66.00/Share from $50.00 by Needham

Dow Jones
·
Aug 13

U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte

Reuters
·
Aug 13

Top Midday Stories: Consumer Prices Rise 3.4% YoY in July; CoreWeave Q2 Loss Narrower Than Expectations

MT Newswires Live
·
Aug 12

Ami Fadia Reiterates Buy on Definium (DFTX) as Strong Phase 3 VOYAGE Data Support Unchanged $50 Price Target

TIPRANKS
·
Aug 12

Exchange-Traded Funds, Equity Futures Gain Pre-Bell Wednesday Amid In-Line Consumer Inflation Data, Tech Gains

MT Newswires Live
·
Aug 12

Definium Therapeutics Posts Phase 3 Voyage Topline Results Presentation

Reuters
·
Aug 12

Definium Therapeutics Shares Jump 22% Premarket After Co's Anxiety Disorder Drug Meets Late-Stage Trial Goal

THOMSON REUTERS
·
Aug 12

Definium Says DT120 Phase 3 GAD Study Shows 5.4-Point HAM-A Benefit vs Placebo

MT Newswires Live
·
Aug 12

Definium Therapeutics Says Anxiety Treatment Met Primary Endpoint in Late-Stage Trial

Dow Jones
·
Aug 12

Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 Odt in Generalized Anxiety Disorder

THOMSON REUTERS
·
Aug 12

Definium Therapeutics: Phase 3 Voyage Study of DT120 Odt Met Primary & Key Secondary Efficacy Endpoints

THOMSON REUTERS
·
Aug 12

Definium Therapeutics: Participants on DT120 Odt Achieved Statistically Significant Reduction in Hamilton Anxiety Rating Scale Score

THOMSON REUTERS
·
Aug 12

Definium Says LSD-Based Pill Reduces Anxiety in Late-Stage Study

Reuters
·
Aug 12

Definium Therapeutics: DT120 Odt Generally Well Tolerated in Study, no New Safety Signals Including no Suicidality Signal

THOMSON REUTERS
·
Aug 12

NASDAQ Trade Halt Halt News Pending at 06:55 Am

Reuters
·
Aug 12

Evercore ISI Sticks to Its Buy Rating for Definium Therapeutics (DFTX)

TIPRANKS
·
Aug 10

Definium Therapeutics (DFTX) Is Up 6.0% After Strong DT120 Data Amid Wider Q2 Net Loss

Simply Wall St.
·
Aug 09

Definium Therapeutics: Buy Rating Reiterated on Strong Clinical and Financial Positioning; $74 Price Target Maintained

TIPRANKS
·
Aug 08

Definium Therapeutics (DFTX) Gets a Buy from Jefferies

TIPRANKS
·
Aug 08
More